"Global Genome Engineering Market Overview:
Global Genome Engineering Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global Genome Engineering Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Genome Engineering involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Genome Engineering Market:
The Genome Engineering Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Genome Engineering Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Genome Engineering Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Genome Engineering market has been segmented into:
CRISPR
TALEN
ZFN
Others
By Application, Genome Engineering market has been segmented into:
Cell Line Engineering and Genetic Engineering
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Genome Engineering market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Genome Engineering market.
Top Key Players Covered in Genome Engineering market are:
Thermo Fisher Scientific Inc.
CRISPR Therapeutics AG
Intellia Therapeuticsinc.
Editas Medicineinc.
Sangamo Therapeuticsinc.
Bluebird Bioinc.
Cellectis S.A.
Merck KGaA
New England Biolabs
Agilent Technologiesinc.
Genscript
Synbio Technologies
Creative Biogene
Eurofins Scientific
Regeneron Pharmaceuticals Inc.
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Genome Engineering Market by Type
4.1 Genome Engineering Market Snapshot and Growth Engine
4.2 Genome Engineering Market Overview
4.3 CRISPR
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 CRISPR: Geographic Segmentation Analysis
4.4 TALEN
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 TALEN: Geographic Segmentation Analysis
4.5 ZFN
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 ZFN: Geographic Segmentation Analysis
4.6 Others
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Others: Geographic Segmentation Analysis
Chapter 5: Genome Engineering Market by Application
5.1 Genome Engineering Market Snapshot and Growth Engine
5.2 Genome Engineering Market Overview
5.3 Cell Line Engineering and Genetic Engineering
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Cell Line Engineering and Genetic Engineering: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Genome Engineering Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 THERMO FISHER SCIENTIFIC INC.
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 CRISPR THERAPEUTICS AG
6.4 INTELLIA THERAPEUTICSINC.
6.5 EDITAS MEDICINEINC.
6.6 SANGAMO THERAPEUTICSINC.
6.7 BLUEBIRD BIOINC.
6.8 CELLECTIS S.A.
6.9 MERCK KGAA
6.10 NEW ENGLAND BIOLABS
6.11 AGILENT TECHNOLOGIESINC.
6.12 GENSCRIPT
6.13 SYNBIO TECHNOLOGIES
6.14 CREATIVE BIOGENE
6.15 EUROFINS SCIENTIFIC
6.16 REGENERON PHARMACEUTICALS INC.
Chapter 7: Global Genome Engineering Market By Region
7.1 Overview
7.2. North America Genome Engineering Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 CRISPR
7.2.4.2 TALEN
7.2.4.3 ZFN
7.2.4.4 Others
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Cell Line Engineering and Genetic Engineering
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Genome Engineering Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 CRISPR
7.3.4.2 TALEN
7.3.4.3 ZFN
7.3.4.4 Others
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Cell Line Engineering and Genetic Engineering
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Genome Engineering Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 CRISPR
7.4.4.2 TALEN
7.4.4.3 ZFN
7.4.4.4 Others
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Cell Line Engineering and Genetic Engineering
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Genome Engineering Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 CRISPR
7.5.4.2 TALEN
7.5.4.3 ZFN
7.5.4.4 Others
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Cell Line Engineering and Genetic Engineering
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Genome Engineering Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 CRISPR
7.6.4.2 TALEN
7.6.4.3 ZFN
7.6.4.4 Others
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Cell Line Engineering and Genetic Engineering
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Genome Engineering Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 CRISPR
7.7.4.2 TALEN
7.7.4.3 ZFN
7.7.4.4 Others
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Cell Line Engineering and Genetic Engineering
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Genome Engineering Scope:
|
Report Data
|
Genome Engineering Market
|
|
Genome Engineering Market Size in 2025
|
USD XX million
|
|
Genome Engineering CAGR 2025 - 2032
|
XX%
|
|
Genome Engineering Base Year
|
2024
|
|
Genome Engineering Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Thermo Fisher Scientific Inc., CRISPR Therapeutics AG, Intellia Therapeuticsinc., Editas Medicineinc., Sangamo Therapeuticsinc., Bluebird Bioinc., Cellectis S.A., Merck KGaA, New England Biolabs, Agilent Technologiesinc., Genscript, Synbio Technologies, Creative Biogene, Eurofins Scientific, Regeneron Pharmaceuticals Inc..
|
|
Key Segments
|
By Type
CRISPR
TALEN
ZFN
Others
By Applications
Cell Line Engineering and Genetic Engineering
|
